Antibody Therapeutics (IF=4.5, Oxford University Press)
🔹 Preventing Physical and Chemical Degradation of the LABL-fc-MOGR5, a Bifunctional Peptide Inhibitor, with Formulation Development Approaches.
academic.oup.com/abt/advance-...
#DrugFormulation #Biologics #ProteinStability #CMC